Cidara Therapeutics (CDTX) Stock Chart & Stock Price History $50.53 -0.35 (-0.69%) Closing price 07/11/2025 04:00 PM EasternExtended Trading$48.64 -1.89 (-3.74%) As of 05:35 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Cidara Therapeutics Stock Price Performance The Cidara Therapeutics (CDTX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 340.16%, with a year-to-date return of 87.98%. In the past month, the stock has increased 121.23%, reflecting recent market activity. As of the latest close, Cidara Therapeutics traded at $50.53 with a market cap of $1.02 billion and volume of 496,771 shares. Five years ago, the stock traded at a split-adjusted price of $71.00, representing a 28.83% decrease over that period. At the time, it had a market cap of $154.19 million and a volume of 6,090 shares. Receive CDTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cidara Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-0.84%1 Month Performance+121.23%3 Month Performance+169.64%Year-To-Date Performance+87.98%1 Year Performance+340.16%5 Year Performance-28.83% CDTX Stock Chart for Monday, July, 14, 2025 CDTX Chart by TradingView Cidara Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/11/2025$50.88$50.53-0.69%$52.50$48.37496,771 shs$1.02 billion07/10/2025$50.96$50.88-0.16%$52.31$49.31458,434 shs$1.03 billion07/09/2025$50.45$50.96+1.01%$52.33$47.691.25 million shs$1.03 billion07/08/2025$48.30$50.45+4.45%$50.66$45.871.17 million shs$1.02 billion07/07/2025$47.80$48.30+1.06%$48.52$45.59764,562 shs$973.73 million07/04/2025$47.80$47.80$49.37$46.39412,729 shs$963.55 million07/03/2025$47.87$47.80-0.16%$49.37$46.39412,729 shs$583.58 million07/02/2025$49.03$47.87-2.37%$48.76$44.461.16 million shs$584.49 million07/01/2025$48.71$49.03+0.66%$49.25$45.00837,637 shs$598.66 million06/30/2025$49.45$48.71-1.50%$50.48$46.181.15 million shs$611.16 million Get the Latest News and Ratings for CDTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cidara Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 06/27/2025$48.03$49.45+2.96%$49.50$45.423.75 million shs$620.60 million06/26/2025$49.33$48.03-2.64%$51.46$47.101.94 million shs$602.78 million06/25/2025$46.84$49.33+5.32%$50.00$43.003.65 million shs$619.09 million06/24/2025$44.95$46.84+4.20%$56.83$43.043.47 million shs$587.84 million06/23/2025$21.02$44.95+113.84%$45.39$37.766.58 million shs$564.12 million06/20/2025$21.31$21.02-1.36%$21.53$20.16392,133 shs$263.80 million06/19/2025$21.31$21.31$22.60$21.25127,800 shs$267.44 million06/18/2025$22.10$21.31-3.57%$22.60$21.25127,800 shs$267.44 million06/17/2025$22.41$22.10-1.38%$22.44$21.14204,127 shs$277.29 million06/16/2025$22.84$22.41-1.88%$23.86$22.30120,261 shs$281.18 million06/13/2025$24.26$22.84-5.85%$24.19$22.84239,404 shs$286.57 million Related Companies Bausch Health Cos Stock Chart ImmunityBio Stock Chart Gemini Therapeutics Stock Chart Arrowhead Pharmaceuticals Stock Chart Apellis Pharmaceuticals Stock Chart Twist Bioscience Stock Chart Vericel Stock Chart NewAmsterdam Pharma Stock Chart Denali Therapeutics Stock Chart Kiniksa Pharmaceuticals International Stock Chart Receive CDTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cidara Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CDTX) was last updated on 7/14/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredA new rule goes live in July — and the banks are quietly cashing inA major change is quietly going into effect this July — and Wall Street is already positioning for it. Big ...American Alternative | SponsoredThis Social Security Shift Could Boost Benefits by 400%If you currently collect Social Security—or plan to in the future—this may be one of the most important update...InvestorPlace | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredTrump’s biggest move, misreportedThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cidara Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cidara Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CDTX Stock Alerts